Optimizing immunization in pediatric special risk groups

References

• Ljungman P, Cordonnier C, Einsele H et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant.44(8), 521–526 (2009).
   PubMed Web of Science ®Google Scholar
• Geretti AM, Doyle T. Immunization for HIV-positive individuals. Curr. Opin. Infect. Dis.23(1), 32–38 (2010).
   PubMed Web of Science ®Google Scholar
• Price VE, Dutta S, Blanchette VS et al. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Pediatr. Blood Cancer46(5), 597–603 (2006).
   PubMed Web of Science ®Google Scholar
• Melmed GY, Ippoliti AF, Papadakis KA et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am. J. Gastroenterol.101(8), 1834–1840 (2006).
   PubMed Web of Science ®Google Scholar
• Crawford NW, Vivien Y, Hunt RW, Barfield C, Gelbart B, Buttery JP. Immunisation practices in infants born prematurely: neonatologists’ survey and clinical audit. J. Paed. Child Health45(10), 602–609 (2009).
   PubMed Web of Science ®Google Scholar
• Biancone L, Maria P, Giovanna Del Vecchio B et al. Hepatitis B and C virus infection in Crohn’s disease. Inflamm. Bowel Dis.7(4), 287–294 (2001).
   PubMed Web of Science ®Google Scholar
• Ojiro K, Naganuma M, Ebinuma H et al. Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab. J. Gastroenterol.43(5), 397–401 (2008).
   PubMed Web of Science ®Google Scholar
• Vonkeman H, ten Napel C, Rasker H, van de Laar M. Disseminated primary varicella infection during infliximab treatment. J. Rheumatol.31(12), 2517–2518 (2004).
   PubMed Web of Science ®Google Scholar
• Galea SA, Sweet A, Beninger P et al. The safety profile of varicella vaccine: a 10 year review. J. Infect. Dis.197(Suppl. 2), S165–S169 (2008).
   PubMed Web of Science ®Google Scholar
• Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA267(9), 1237–1241 (1992).
   PubMed Web of Science ®Google Scholar
• Ritz MA, Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn’s disease. Inflamm. Bowel Dis.7(4), 327 (2001).
   PubMed Web of Science ®Google Scholar
• Bhatia J, Bratcher J, Korelitz B et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J. Gastroenterol.12(38), 6167–6171 (2006).
   PubMed Web of Science ®Google Scholar
• Kane S, Khatibi B, Reddy D. Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am. J. Gastroenterol.103(3), 631–636 (2008).
   PubMed Web of Science ®Google Scholar
• Hjuler T, Wohlfahrt J, Staum Kaltoft M, Koch A, Biggar RJ, Melbye M. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics122(1), e26–e32 (2008).
   PubMed Web of Science ®Google Scholar
• Fiore AE, Shay DK, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm. Rep.57(RR-7), 1–60 (2008).
   PubMedGoogle Scholar
• Langkamp DL, Davis JP. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J. Pediatr.128(5 Pt 1), 654–659 (1996).
   PubMed Web of Science ®Google Scholar
• Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paed. Resp. Rev.9(3), 201–212 (2008).
   Google Scholar
• Dylag AM, Shah SI. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics122(3), e550–e555 (2008).
   PubMed Web of Science ®Google Scholar
• CDC. Trends in childhood cancer mortality – United States 1990–2004. MMWR Morb. Mortal. Wkly Rep.56, 1257–1261 (2007).
   PubMedGoogle Scholar
• Azburg M. Vaccination in the immunocompromised child. Pediatr. Infect. Dis. J.28(3), 233–236 (2009).
   PubMed Web of Science ®Google Scholar
• Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines. Nat. Rev. Immunol.9, 210–220 (2009).
   Google Scholar
• Zignol M, Peracchi M, Tridello G et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer101(3), 635–641 (2004).
   PubMed Web of Science ®Google Scholar
• Patel SR, Ortin M, Bernard JC et al. Revaccination of children after completion of standard chemotherapy for acute leukaemia. Clin. Infect. Dis.44, 635–642 (2007).
   PubMed Web of Science ®Google Scholar
• Gershon AA, Steinberg SP. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N. Engl. J. Med.320(14), 892–897 (1989).
   PubMed Web of Science ®Google Scholar
• Gershon AA, LaRussa P, Steinberg S, Mervish N, Lo SH, Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J. Infect. Dis.173(2), 450–453 (1996).
   PubMed Web of Science ®Google Scholar
• Lawn JE, Osrin D, Adler A, Cousens S. Four million neonatal deaths: counting and attribution of cause of death. Paediatr. Perinat. Epidemiol.22(5), 410–416 (2008).
   PubMed Web of Science ®Google Scholar
• Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol.4(7), 553–564 (2004).
   PubMed Web of Science ®Google Scholar
• Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol.7(5), 379–390 (2007).
   PubMed Web of Science ®Google Scholar
• Siegrist C-A. Neonatal and early life vaccinology. Vaccine19(25–26), 3331–3346 (2001).
   PubMed Web of Science ®Google Scholar
• Shinefield H, Black S, Ray P, Fireman B, Schwalbe J, Lewis E. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr. Infect. Dis. J.21(3), 182–186 (2002).
   PubMed Web of Science ®Google Scholar
• D’Angio CT. Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability. Paediatr. Drug9(1), 17–32 (2007).
   PubMedGoogle Scholar
• Vazquez L, Garcia F, Ruttimann R, Coconier G, Jacquet J-M, Schuerman L. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Acta Paediatr.97(9), 1243–1249 (2008).
   PubMed Web of Science ®Google Scholar
• Siegrist C-A, Córdova M, Brandt C et al. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine16(14–15), 1409–1414 (1998).
   PubMed Web of Science ®Google Scholar
• Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics87(6), 823–828 (1991).
   PubMed Web of Science ®Google Scholar
• Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med.359(15), 1555–1564 (2008).
   PubMed Web of Science ®Google Scholar
• Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet369(9563), 767–778 (2007).
   PubMed Web of Science ®Google Scholar
• Gartlehner G, Hansen R, Jonas B, Thieda P, Lohr K. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin. Rheum.27(1), 67–76 (2008).
   PubMed Web of Science ®Google Scholar
• Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology126(6), 1504–1517 (2004).
   PubMed Web of Science ®Google Scholar
• Phavichitr N, Cameron DJS, Catto-Smith AG. Increasing incidence of Crohn’s disease in Victorian children. J. Gastroenterol. Hepatol.18(3), 329–332 (2003).
   PubMed Web of Science ®Google Scholar
• Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB. Inflammatory bowel disease. Arch. Dis. Child.91(5), 426–432 (2006).
   PubMed Web of Science ®Google Scholar
• Yamamoto-Furusho JK, Podolsky DK. Innate immunity in inflammatory bowel disease. World J. Gastroenterol.13(42), 5577–5580 (2007).
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature411(6837), 603–606 (2001).
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science314(5804), 1461–1463 (2006).
   PubMed Web of Science ®Google Scholar
• Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am. J. Gastroenterol.105(6), 1231–1238 (2010).
   PubMed Web of Science ®Google Scholar
• Lu Y, Jacobson D, Bousvaros A. Immunizations in patients with inflammatory bowel disease. Inflamm. Bowel Dis.15(9), 1417–1423 (2009).
   PubMed Web of Science ®Google Scholar
• Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm. Bowel Dis.15(9), 1410–1416 (2009).
   PubMed Web of Science ®Google Scholar
• D’Haens G. Risks and benefits of biologic therapy for inflammatory bowel diseases. Gut56(5), 725–732 (2007).
   PubMed Web of Science ®Google Scholar
• Toruner M, Loftus Jr EV, Harmsen WS et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology134(4), 929–936 (2008).
   PubMed Web of Science ®Google Scholar
• Sands BE, Carmen C, Jeffry K et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm. Bowel Dis.10(5), 677–692 (2004).
   PubMed Web of Science ®Google Scholar
• Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut57(4), 549–558 (2008).
   PubMed Web of Science ®Google Scholar
• Cutolo M, Seriolo B, Pizzorni C et al. Use of glucocorticoids and risk of infections. Autoimmunity Rev.8(2), 153–155 (2008).
   PubMed Web of Science ®Google Scholar
• CDC. Measles pneumonitis following measles–mumps–rubella vaccination of a patient with HIV infection. MMWR Morb. Mortal. Wkly Rep.45(28), 603–606 (1996).
   PubMedGoogle Scholar
• Mitus A, Holloway A, Evans AE, Enders JF. Attenuated measles vaccine in children with acute leukemia. Am. J. Dis. Child.103, 413–418 (1962).
   PubMedGoogle Scholar
• Lu Y, Bousvaros A. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. J. Pediatr. Gastroenterol. Nutr.50(5), 562–565 (2010).
   PubMed Web of Science ®Google Scholar
• Levin MJ. Varicella vaccination of immunocompromised children. J. Infect. Dis.197(S2), S200–S206 (2008).
   PubMed Web of Science ®Google Scholar
• Buda K, Tubergen DG, Levin MJ. The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol.18(2), 106–112 (1996).
   PubMed Web of Science ®Google Scholar
• Deutsch DE, Olson AD, Kraker S, Dickinson CJ. Overwhelming varicella pneumonia in a patient with Crohn’s disease treated with 6-mercaptopurine. J. Pediatr. Gastroenterol. Nutr.20(3), 351–353 (1995).
   PubMed Web of Science ®Google Scholar
• Kappagoda C, Shaw PJ, Burgess MA, Botham SJ, Cramer LD. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia. J. Paed. Child Health35(4), 341–345 (1999).
   Web of Science ®Google Scholar
• Offit PA, Hackett CJ. Addressing parents’ concerns: do vaccines cause allergic or autoimmune diseases? Pediatrics111(3), 653–659 (2003).
   PubMed Web of Science ®Google Scholar
• Bengtsson C, Kapetanovic MC, Källberg H et al. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Annals Rheum. Dis.69(10), 1831–1833 (2010).
   PubMed Web of Science ®Google Scholar
• Siegrist CA, Lewis EM, Eskola J, Evans SJ, Black SB. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. Pediatr. Infect. Dis. J.26(11), 979–984 (2007).
   PubMed Web of Science ®Google Scholar
• Black S, Eskola J, Siegrist CA et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet374(9707), 2115–2122 (2009).
   PubMed Web of Science ®Google Scholar
• Slade BA, Leidel L, Vellozzi C et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA302(7), 750–757 (2009).
   PubMed Web of Science ®Google Scholar
• Farmaki E, Kanakoudi-Tsakalidou F, Spoulou V et al. The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis. Vaccine28(31), 5109–5113 (2010).
   PubMed Web of Science ®Google Scholar
• Moberley SA, Torzillo P. Pneumococcal polysaccharide vaccine in high risk adults. Br. Med. J.340, c1139 (2010).
   Google Scholar
• O’Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect. Dis.7(9), 597–606 (2007).
   PubMed Web of Science ®Google Scholar
• Russell FM, Carapetis JR, Balloch A et al. Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial. Vaccine28(19), 3341–3349 (2010).
   PubMed Web of Science ®Google Scholar
• Dieter A. Issues in pneumococcal disease and pneumococcal conjugate vaccines: Highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9–13, 2009. Vaccine27(50), 7133–7137 (2009).
   PubMedGoogle Scholar
• Proesmans M. Pneumococcal vaccination: time to move on? Eur. J. Pediatr.169(11), 1435–1437 (2010).
   PubMed Web of Science ®Google Scholar
• Richardson V, Hernandez-Pichardo J, Quintanar-Solares M et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N. Engl. J. Med.362(4), 299–305 (2010).
   PubMed Web of Science ®Google Scholar
• Grimwood K, Buttery JP. Clinical update: rotavirus gastroenteritis and its prevention. Lancet370(9584), 302–304 (2007).
   PubMed Web of Science ®Google Scholar
• Curns A, Steiner C, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J. Infect. Dis.201(11), 1617–1624 (2010).
   PubMed Web of Science ®Google Scholar
• Van der Wielen M, Van Damme P. Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial. Eur. J. Clin. Microbiol. Infect. Dis.27(7), 495–501 (2008).
   PubMed Web of Science ®Google Scholar
• Omenaca F. Safety, reactogenicity and immunogenicity of rix4414 live attenuated human rotavirus vaccine in pre-term infants. Presented at: ICAAC/IDSA Joint Meeting. Washington DC, USA, 25–28 October 2008.
   Google Scholar
• Werther RL, Crawford NW, Boniface K, Kirkwood CD, Smart JM. Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency. J. Allergy Clin. Immunol.124(3), 600 (2009).
   PubMed Web of Science ®Google Scholar
• Patel NC, Hertel PM, Estes MK et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N. Engl. J. Med.362(4), 314–319 (2010).
   PubMed Web of Science ®Google Scholar
• CDC. Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine. MMWR Morb. Mortal. Wkly Rep.59(22), 687–688 (2010).
   PubMedGoogle Scholar
• Adeli MM, Buckley RH. Why newborn screening for severe combined immunodeficiency is essential: a case report. Pediatrics126(2), e465–e469 (2010).
   Google Scholar
• Madhi SA, Cunliffe NA, Steele D et al. Effect of human rotavirus vaccine on severe diarrhea in african infants. N. Engl. J. Med.362(4), 289–298 (2010).
   PubMed Web of Science ®Google Scholar
• CDC. Update: influenza activity – United States, 2009–10 season. MMWR Morb. Mortal. Wkly Rep.59(29), 901–908 (2010).
   PubMedGoogle Scholar
• ANZICII. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N. Engl. J. Med.361(20), 1925–1934 (2009).
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Wright PF, Mitchel EF, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J. Pediatr.137(6), 856–864 (2000).
   PubMed Web of Science ®Google Scholar
• Goossen GM, Kremer LC, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst. Rev. (2), CD006484 (2009).
   Google Scholar
• Lu Y, Jacobson DL, Ashworth LA et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am. J. Gastroenterol.104(2), 444–453 (2009).
   PubMed Web of Science ®Google Scholar
• Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003–2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics116(1), 153–159 (2005).
   PubMed Web of Science ®Google Scholar
• Ostensen M, Almberg K, Koksvik HS. Sex, reproduction, and gynecological disease in young adults with a history of juvenile chronic arthritis. J. Rheumatol.27(7), 1783–1787 (2000).
   PubMed Web of Science ®Google Scholar
• Puukko LR, Hirvonen E, Aalberg V, Hovi L, Rautonen J, Siimes MA. Sexuality of young women surviving leukaemia. Arch. Dis. Child.76(3), 197–202 (1997).
   PubMed Web of Science ®Google Scholar
• Somasekar A, Alcolado R. Genital condylomata in a patient receiving infliximab for Crohn’s disease. Postgrad. Med. J.80(944), 358–359 (2004).
   PubMed Web of Science ®Google Scholar
• Bate J, Patel R, Chisholm J, Heath PT; on behalf of the Supportive Care Group of the Children’s Cancer and Leukaemia G. Immunisation practices of paediatric oncology and shared care oncology consultants: a United Kingdom survey. Pediatr. Blood Cancer54(7), 941–946 (2010).
   PubMed Web of Science ®Google Scholar
• Crawford NW, Heath JA, Buttery JP. Immunisation practices of paediatric oncologists: an Australasian survey. J. Paed. Child Health43(9), 593–596 (2007).
   PubMed Web of Science ®Google Scholar
• Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am. J. Gastroenterol.105(6), 1231–1238 (2010).
   PubMed Web of Science ®Google Scholar
• Chisholm J. Reimmunization after therapy for childhood cancer. Clin. Infect. Dis.44, 643–645 (2007).
   PubMed Web of Science ®Google Scholar
• Crawford NW, Heath JA, Ashley D, Downie P, Buttery JP. Survivors of childhood cancer: an Australian audit of vaccination status after treatment. Pediatr. Blood Cancer54(1), 128–133 (2010).
   PubMed Web of Science ®Google Scholar
• Pradeep J, Watts R, Clunie G. Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Annals Rheum. Dis.66, 837–838 (2007).
   PubMed Web of Science ®Google Scholar
• Karthikeyan A, Agwu JC. Uptake of influenza vaccination among children with diabetes – a re-audit. J. Infect.56(2), 158–159 (2008).
   PubMed Web of Science ®Google Scholar
• Jacobson Vann JC, Szilagyi P. Patient reminder and patient recall systems for improving immunization rates. Cochrane Database (3), CD003941 (2005).
   Google Scholar
• Fiks AG, Grundmeier RW, Biggs LM, Localio AR, Alessandrini EA. Impact of clinical alerts within an electronic health record on routine childhood immunization in an urban pediatric population. Pediatrics120(4), 707–714 (2007).
   PubMed Web of Science ®Google Scholar
• Fiks AG, Hunter KF, Localio AR et al. Impact of electronic health record-based alerts on influenza vaccination for children with asthma. Pediatrics124(1), 159–169 (2009).
   PubMed Web of Science ®Google Scholar
• Skull SA, Nolan TM. Australia needs an expanded immunisation register for further improvements in vaccine delivery and program evaluation. Med. J. Aust.187(9), 504–505 (2007).
   PubMed Web of Science ®Google Scholar
• Finn A, Clarke E, Mytton J. Adolescent immunisation: the next big thing? Arch. Dis. Child. DOI:10.1136/adc.2010.192070 (2010) (Epub ahead of print).
   Google Scholar
• Crawford NW, Buttery JP. Minimising missed opportunities to vaccinate. J. Paed. Child Health44(6), 315–316 (2008).
   PubMed Web of Science ®Google Scholar
• Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect. Dis.6(1), 21–31 (2006).
   PubMed Web of Science ®Google Scholar
• Peres J. Who should get the HPV vaccine? Usage expands amid debate. J. Natl Cancer Inst.102(12), 838–840 (2010).
   PubMedGoogle Scholar
• Halfon N, Newacheck PW. Evolving notions of childhood chronic illness. JAMA303(7), 665–666 (2010).
   PubMed Web of Science ®Google Scholar
• Editorial. A good year for biologics. Nat. Med.16(2), 139 (2010).
   PubMed Web of Science ®Google Scholar
• Gomez M, Mufson MA, Dubovsky F, Knightly C, Zeng W, Losonsky G. Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children. Pediatr. Infect. Dis. J.28(7), 655–658 (2009).
   PubMed Web of Science ®Google Scholar
• Belgi G, Friedmann PS. Traditional therapies: glucocorticoids, azathioprine, methotrexate, hydroxyurea. Clin. Exp. Dermatol.27(7), 546–554 (2002).
   PubMed Web of Science ®Google Scholar